- Home
- RMM vs SMTI Comparison
RMM vs SMTI Comparison
Compare RMM & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMM
- SMTI
- Stock Information
- Founded
- RMM 2019
- SMTI 1982
- Country
- RMM United States
- SMTI United States
- Employees
- RMM N/A
- SMTI N/A
- Industry
- RMM Trusts Except Educational Religious and Charitable
- SMTI Medical/Dental Instruments
- Sector
- RMM Finance
- SMTI Health Care
- Exchange
- RMM Nasdaq
- SMTI Nasdaq
- Market Cap
- RMM 314.6M
- SMTI 288.2M
- IPO Year
- RMM N/A
- SMTI N/A
- Fundamental
- Price
- RMM $14.61
- SMTI $34.94
- Analyst Decision
- RMM
- SMTI Strong Buy
- Analyst Count
- RMM 0
- SMTI 2
- Target Price
- RMM N/A
- SMTI $47.00
- AVG Volume (30 Days)
- RMM 66.5K
- SMTI 32.2K
- Earning Date
- RMM 01-01-0001
- SMTI 11-12-2024
- Dividend Yield
- RMM 7.33%
- SMTI N/A
- EPS Growth
- RMM N/A
- SMTI N/A
- EPS
- RMM 0.96
- SMTI N/A
- Revenue
- RMM N/A
- SMTI $78,056,873.00
- Revenue This Year
- RMM N/A
- SMTI $29.95
- Revenue Next Year
- RMM N/A
- SMTI $19.68
- P/E Ratio
- RMM $15.55
- SMTI N/A
- Revenue Growth
- RMM N/A
- SMTI 24.66
- 52 Week Low
- RMM $12.32
- SMTI $26.00
- 52 Week High
- RMM $16.10
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- RMM 24.39
- SMTI 51.01
- Support Level
- RMM $14.43
- SMTI $31.13
- Resistance Level
- RMM $16.29
- SMTI $35.08
- Average True Range (ATR)
- RMM 0.22
- SMTI 1.89
- MACD
- RMM -0.12
- SMTI -0.23
- Stochastic Oscillator
- RMM 9.68
- SMTI 59.81
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.